YS Biopharma Co Ltd
NASDAQ:LSB
YS Biopharma Co Ltd
NASDAQ:LSB
Price:
0.627
USD
-24.46%
Market Closed
Market Cap:
$25.8m
Cash Flow Statement
Cash Flow Statement
YS Biopharma Co Ltd
YS Biopharma Co Ltd
Currency: CNY
| Mar-2023 | Sep-2023 | Mar-2024 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(145)
|
(309)
|
(433)
|
|
| Depreciation & Amortization |
37
|
39
|
42
|
|
| Change in Deffered Taxes |
1
|
(0)
|
(22)
|
|
| Stock-Based Compensation |
4
|
0
|
10
|
|
| Other Non-Cash Items |
18
|
21
|
164
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
|
| Cash Interest Paid |
27
|
25
|
30
|
|
| Change in Working Capital |
(93)
|
28
|
(46)
|
|
| Cash from Operating Activities |
(182)
N/A
|
(221)
-21%
|
(295)
-34%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(57)
|
(62)
|
(44)
|
|
| Other Items |
0
|
0
|
0
|
|
| Cash from Investing Activities |
(57)
N/A
|
(61)
-8%
|
(44)
+28%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
0
|
0
|
284
|
|
| Net Issuance of Debt |
101
|
94
|
(79)
|
|
| Other |
217
|
0
|
0
|
|
| Cash from Financing Activities |
317
N/A
|
310
-2%
|
205
-34%
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
21
|
5
|
10
|
|
| Net Change in Cash |
99
N/A
|
33
-67%
|
(124)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(240)
N/A
|
(283)
-18%
|
(339)
-20%
|
|
Switch to:
Switch to:
See Also
Discover More
